Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionIntellectus Partners, LLC
Latest Disclosed Ownership12,299 shares
Latest Disclosed Value $ 1,262,743
Intellectus Partners, LLC reports 12.46% decrease in ownership of ABL / Abbott Laboratories

On April 10, 2026 - Intellectus Partners, LLC filed a 13F-HR form disclosing ownership of 12,299 shares of Abbott Laboratories (DE:ABL) valued at $1,092,397 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 14,049 shares of Abbott Laboratories. This represents a change in shares of -12.46% during the quarter. The current value of the position is $925,131 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 12,299 -1,750 -12.46 1,263 -28.30 0.2578
2026-02-10 2025-12-31 13F ABBOTT LABS COM 002824100 14,049 5,155 57.96 1,760 47.77 0.3401
2025-11-12 2025-09-30 13F ABBOTT LABS COM 002824100 8,894 -45 -0.50 1,191 -1.98 0.2308
2025-08-05 2025-06-30 13F ABBOTT LABS COM 002824100 8,939 1 0.01 1,216 2.53 0.2625
2025-04-11 2025-03-31 13F ABBOTT LABS COM 002824100 8,938 -237 -2.58 1,186 14.27 0.2925
2025-02-07 2024-12-31 13F ABBOTT LABS COM 002824100 9,175 1 0.01 1,038 -0.77 0.2297
2024-11-06 2024-09-30 13F ABBOTT LABS COM 002824100 9,174 1 0.01 1,046 9.65 0.2673
2024-07-18 2024-06-30 13F ABBOTT LABS COM 002824100 9,173 -847 -8.45 953 -16.26 0.2602
2024-05-03 2024-03-31 13F ABBOTT LABS COM 002824100 10,020 1,707 20.53 1,139 24.37 0.2995
2024-02-05 2023-12-31 13F ABBOTT LABS COM 002824100 8,313 -102 -1.21 915 12.27 0.2641
2023-10-25 2023-09-30 13F ABBOTT LABS COM 002824100 8,415 -106 -1.24 815 -12.18 0.2578
2023-07-31 2023-06-30 13F ABBOTT LABS COM 002824100 8,521 2 0.02 929 7.66 0.2788
2023-05-04 2023-03-31 13F ABBOTT LABS COM 002824100 8,519 2 0.02 863 -7.81 0.2724
2023-02-02 2022-12-31 13F Abbott Laboratories Equity 002824100 8,517 2 0.02 935 13.47 0.3255
2022-11-14 2022-09-30 13F Abbott Laboratories Equity 002824100 8,515 446 5.53 824 -6.04 0.2931
2022-08-12 2022-06-30 13F Abbott Laboratories Common Stock 002824100 8,069 -4,223 -34.36 877 -39.73 0.3013
2022-05-16 2022-03-31 13F Abbott Laboratories Common Stock 002824100 12,292 -674 -5.20 1,455 -20.27 0.4343
2022-02-14 2021-12-31 13F Abbott Laboratories Common Stock 002824100 12,966 -183 -1.39 1,825 17.51 0.4652
2021-11-16 2021-09-30 13F Abbott Laboratories Equity 002824100 13,149 2 0.02 1,553 1.90 0.3759
2021-08-13 2021-06-30 13F Abbott Laboratories Equity 002824100 13,147 468 3.69 1,524 0.33 0.3436
2021-05-17 2021-03-31 13F Abbott Laboratories Equity 002824100 12,679 -1 -0.01 1,519 9.44 0.4172
2021-02-18 2020-12-31 13F/A-1 Abbott Laboratories Common Stock 002824100 12,680 400 3.26 1,388 3.89 0.4154
2021-02-12 2020-12-31 13F Abbott Laboratories Common Stock 002824100 673 -11,607 1,388 412,693.5988
2020-11-16 2020-09-30 13F Abbott Laboratories Common Stock 002824100 12,280 -1,534 -11.10 1,336 5.78 0.5048
2020-08-14 2020-06-30 13F Abbott Laboratories Equity 002824100 13,814 665 5.06 1,263 21.68 0.4895
2020-05-14 2020-03-31 13F Abbott Laboratories Equity 002824100 13,149 5,428 70.30 1,038 54.69 0.4946
2020-01-24 2019-12-31 13F Abbott Laboratories Common Stock 002824100 7,721 7,721 671 0.2730
2019-05-15 2019-03-31 13F Abbott Laboratories COM 002824100 0 -20 -100.00 0 -100.00
2019-02-14 2018-12-31 13F Abbott Laboratories COM 002824100 20 -934 -97.90 1 -98.57 0.0007
2018-11-15 2018-09-30 13F Abbott Laboratories Equity 002824100 954 0 0.00 70 20.69 0.0245
2018-08-14 2018-06-30 13F Abbott Laboratories Equity 002824100 954 0 0.00 58 1.75 0.0212
2018-05-15 2018-03-31 13F Abbott Laboratories Equity 002824100 954 0 0.00 57 5.56 0.0196
2018-02-13 2017-12-31 13F Abbott Laboratories Equity 002824100 954 0 0.00 54 5.88 0.0202
2017-11-14 2017-09-30 13F Abbott Laboratories Equity 002824100 954 -170 -15.12 51 -7.27 0.0211
2017-08-15 2017-06-30 13F Abbott Laboratories Equity 002824100 1,124 190 20.34 55 34.15 0.0248
2017-05-08 2017-03-31 13F Abbott Laboratories Equity 002824100 934 0 0.00 41 13.89 0.0208
2017-02-14 2016-12-31 13F Abbott Laboratories Equity 002824100 934 934 36 0.0187
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.